OPINION AND ORDER
Plaintiff Interbrew S.A. (“Interbrew”) brings this action for violations of § 10(b) of *427 the 1934 Securities Exchange Act and Rule 10b-5 promulgated thereunder. Plaintiff also asserts pendant state law claims for common law fraud and negligent misrepresentation. Subject matter jurisdiction is premised upon a federal question, 28 U.S.C. § 1331, and principles of supplemental jurisdiction, 28 U.S.C. § 1367(a).
Interbrew seeks damages resulting from allegedly fraudulent misrepresentations by EdperBrascan’s corporate predecessor, Bras-ean Limited (“Brascan”), regarding its obligation to purchase for cash, or its equivalent, certain securities held by John Labatt Limited (“Labatt”). Interbrew alleges that these misrepresentations, upon which it relied to its detriment, caused it to purchase and hold Labatt shares at an artificially inflated price.
Defendant EdperBrascan moves to dismiss the Complaint pursuant to Fed.R.Civ.P. 9(b), 12(b)(1), 12(b)(2) and 12(b)(6), claiming that the Complaint fails to state a claim upon which relief can be granted, fails to plead fraud with particularity, and that this Court lacks subject matter jurisdiction over the case and personal jurisdiction over the Defendant. In the alternative, Defendant seeks to stay or dismiss this action in deference to related litigation pending in Canada or to dismiss the action on the ground of forum non conveniens.
I. Standards Under Rule 12(b)
Before a court can consider a
forum non conveniens
motion, it must first determine whether it has jurisdiction over the case and the parties.
See Monsanto International Sales Co., Inc. v. Hanjin Container Lines, Ltd.,
88 Civ. 1673,
Defendant urges that because it made a “facial” challenge to subject matter jurisdiction pursuant to Rule 12(b)(1) — contesting only “the sufficiency of the jurisdictional facts alleged, not the facts themselves,”
Poodry v. Tonawanda Band of Seneca Indians,
II. Background
Defendant EdperBrascan is a corporation organized under the laws of Ontario, Canada, formed through the combination of Brascan and The Edper Group Limited on or about August 1,1997. Its voting shares are traded on the American Stock Exchange, the Toronto Stock Exchange and elsewhere.
Plaintiff Interbrew is a société anonyme organized under the laws of Belgium, with its headquarters in Brussels, Belgium. Inter-brew makes and sells beer and other products. Through a wholly owned subsidiary, Interbrew owns 100% of the shares of Labatt Brewing Company Ltd. (a corporate successor to Labatt, a corporation organized under the laws of Canada). In addition, Interbrew indirectly owns 78% of the shares of Labatt USA L.L.C., based in Norwalk, Connecticut, and 78% of the shares of Latrobe Brewing Company L.L.C., based in Latrobe, Pennsylvania.
From approximately 1980 until March 8, 1993, Brascan owned roughly 38% of the outstanding common shares of Labatt, with the remainder owned by public shareholders. Due to this substantial investment and the presence of various Brascan directors and officers on the Labatt Board of Directors, *428 Brascan exercised effective control of Labatt during this time. See Complaint (“Cmplt.”) at ¶ 12.
During the years of Brascan’s control of Labatt, Brascan caused Labatt to make investments of approximately (Cdn) $300 million in Epsim Investments Limited (“Epsim”) and Mico Investments Ltd. (“Mico”), other entities also controlled by Brascan. See Cmplt. at ¶¶ 3, 13, 14. The securities of these companies were not traded on any established market nor were they freely resalable. Thus, Labatt’s investments in these companies would be virtually worthless to Labatt without some mechanism by which it could convert these investments into cash or freely-traded, marketable securities. See id.
In February 1993, Brascan announced its intention to sell its 38% stake in Labatt. In connection with that sale, Brascan officials represented to the Labatt Board of Directors that Labatt’s investments in Epsim and Mico would be liquidated at book value and that, if any of the investments remained unsold at the end of five years (i.e. by the end of March, 1998), Brascan would purchase them for cash or market-traded securities which could be quickly converted into cash. See Cmplt. at ¶¶3, 15. Brascan repeated the substance of these representations in its prospectus, through which it registered its shares of Labatt and sold them to the public on March 8,1993. See Cmplt. at ¶ 16.
These representation took other forms as well. On March 9, 1993, the day after Brascan’s shares had been sold, Brascan confirmed its commitment to monetize the investments by signing an agreement with Labatt (“the Agreement”) which would facilitate the monetization of the Epsim and Mico investments at book value. See Cmplt. at ¶¶ 17, 18. Subsequently, on March 11, 1993, Labatt’s Board of Directors, including those members who were also Brascan Directors, unanimously approved Labatt’s financial statements, which classified the Epsim and Mico investments as long-term assets at their full book value. See Cmplt. at ¶¶ 4, 19. On August 10, 1993, Labatt filed its Annual Report for the fiscal year ending April 30, 1993, containing the financial statements based in turn on the Agreement signed with Brascan, with the U.S. Securities and Exchange Commission (the “SEC”). See Cmplt. at ¶20. This classification also appeared in Labatt’s Annual Report for the fiscal year ending April 30, 1994, filed with the SEC on August 16, 1994 (the “1994 Annual Report”).
Relying on these and other representations concerning the value of Labatt’s investments (and thus the value of Labatt), Interbrew’s financial advisors determined the price they were willing to pay for Labatt common shares. See Cmplt. at ¶ 25. Ultimately, on July 26, 1995, pursuant to a tender offer dated June 14,1995, Interbrew purchased all of the outstanding common shares of Labatt at a price of (Cdn) $28.50 per share, for a total price of approximately (Cdn) $2.7 billion. See Cmplt. at ¶¶ 24, 26. Of this price, the value of Labatt’s investment in Epsim and Mico, with a full book value then of about (Cdn) $158 million, accounted for approximately (Cdn) $1.70 per share.
By March 31,1998, Labatt’s investments in Epsim and Mico had a book value of approximately (Cdn) $135.5 million. See Cmplt. at ¶28. Interbrew alleges that EdperBrasean now offers to monetize this investment by providing shares in another entity that La-batt Brewing (Labatt’s successor) cannot convert to cash for an equivalent amount, significantly devaluing the worth of the initial investments. See Cmplt. at ¶¶ 29, 31. Thus, Interbrew alleges that it effectively purchased and held Labatt shares at an artificially inflated price. See Cmplt. at ¶ 1.
III. Subject Matter Jurisdiction
A. Standard for Determining Jurisdiction
The Securities Exchange Act is silent as to its extraterritorial application, as has long been recognized.
See Itoba Ltd. v. Lep Group PLC,
To guide courts in this effort, two jurisdictional tests have emerged: the “conduct test”, as announced in
Leasco Data Processing Equip. Corp. v. Maxwell,
Under the conduct test, a federal court has subject matter jurisdiction if (1) the defendant’s activities in the United States were more than “merely preparatory” to a securities fraud conducted elsewhere,
Bersch,
Under the “effects” test, a federal court has subject matter jurisdiction if the defendant’s conduct abroad has “substantial” impact in the United States.
See Alfadda,
The Second Circuit has noted that these tests need not be considered separately, but that “an admixture or combination of the two often gives a better picture of whether there is sufficient United States involvement to justify the exercise of jurisdiction by an American court.”
Itoba,
In a case this Court finds highly instructive, if not controlling, the Second Circuit recently addressed the extraterritorial application of the anti-fraud provisions of U.S. securities laws with regard to primarily foreign actors and events. In
Europe and Overseas Commodity Traders v. Banque Paribas London,
B. Application of the Standards to the Instant Dispute
1. The Effects Test
According to the Complaint, “[a]s a result of Brascan’s fraudulent misrepresentations, Labatt common shares traded in 1995 at an artificially inflated price, causing Inter-brew to suffer damages when it purchased and held shares at the artificially inflated price.” See Cmplt. at ¶ 7. The “effects” test directs attention to the impact of overseas activity on U.S. investors and securities traded on U.S. securities exchanges. Considered from this vantage, the alleged effects on U.S. interests are minimal: Plaintiff is a Belgian organization suing a Canadian defendant for alleged losses sustained in connection with the purchase of a Canadian corporation, whose stock is traded on a Canadian stock exchange. Interbrew alleges no effect on a U.S. affiliated company.
*430
While Interbrew does draw attention to U.S. investors who participated in this transaction as owners of the approximately 25% of Labatt’s shares tendered by U.S. investors (about 387 U.S. residents in about 40 states and the District of Columbia,
see
Cmplt. at ¶ 24), these investors were neither the intended nor the actual “victims” of Brasean’s purported scheme to defraud. The only justification for considering their participation as a basis for the exercise of jurisdiction would be to use the securities laws to “insure the maintenance of fair and honest markets” as Interbrew urges. The anti-fraud provisions of the U.S. securities laws would then be used to address general market conditions rather than redress specific harms suffered by some U.S.-interested party, a goal specifically foreclosed by numerous interpretations of the securities laws.
See, e.g., Koal Industries Corp. v. Asland, S.A.,
To the extent that Brascan’s allegedly misleading statements caused specific harmful effects, those effects were felt by Interbrew, a Belgian organization, and its investors (none of whom are alleged to be Americans). Thus, “there is ... no U.S. entity that Congress could have wished to protect from the machination of swindlers.”
Europe and Overseas,
2. The Conduct Test
Turning to the conduct test, it is the defendant’s activities in the United States that are relevant: Interbrew must establish that Brascan’s U.S.-based activities were more than “merely preparatory” to a securities fraud conducted elsewhere,
Bersch,
Interbrew alleges that from 1993 through 1997, Brascan repeatedly made material misrepresentations concerning its obligations to fully monetize Labatt’s investments in Epsim and Mico: in meetings with Interbrew officers, see Cmplt. at ¶¶ 2, 5, 21, 22, 27, 34, in Brascan’s publicly-filed documents, see Cmplt. at ¶¶ 2, 4, 6, 16, 21, 26, 34, to “the market,” see Cmplt. at ¶¶ 21, 22, 35, and in meetings with Labatt’s Directors and outside auditors, see Cmplt. at ¶¶ 2, 4, 15, 17, 19, 22, 34, which resulted in significant overstatements of assets in Labatt’s financial statements, filed with the SEC as part of its Annual Reports. See Cmplt. at ¶¶2, 4, 20, 34.
These misrepresentations fall into two categories: (1) those made prior to and relied on in connection with Interbrew’s purchase of Labatt’s shares and (2) those made after Interbrew’s purchase of Labatt was complete, in which Interbrew alleges that Bras-can continued perpetrating the fraud in further conversations and in public filings. See, e.g., Cmplt. at ¶¶ 6 and 26, where Interbrew alleges that following its purchase of Labatt shares, Brascan continued to state in documents filed publicly in the U.S. that it was obligated to monetize the Labatt investments at book value by the end of March 1998, and Interbrew continued to hold its shares of Labatt.
Interbrew alleges that had it known that Brascan never intended to fully monetize La-batt’s investments in Epsim and Mico it would not have been willing to purchase La-batt’s shares at the same price. See Cmplt. at ¶ 25. Interbrew does not allege, however, that given similar knowledge it would not have been willing to maintain its investment in Labatt. See, e.g., Cmplt. at ¶¶ 25, 36, 37. For purposes of this motion, this failure moots Interbrew’s reliance on its additional allegations that Brascan continued to perpetrate the fraud in further filings with the SEC after Interbrew completed its purchase of Labatt.
Nor would this defect likely be cured by an aménded Complaint. Title 15 U.S.C. § 78j,
*431
under which Plaintiff brings this action, relates to fraud “in connection with the purchase or sale of any security..
1
While the inclusion of the “in connection with” language limits the fraud-related provisions to securities-related fraud rather than to fraud committed generally, courts have interpreted the phrase to require, as a threshold matter, that the fraud actually have affected a purchase or sales transaction, not the mere retention of a security.
See Manela v. Gottleib,
91 Civ. 5510,
Therefore, I am only considering those alleged misrepresentations made prior to the close of the Offer to Purchase, which occurred on July 26, 1995, 2 and excluding from consideration those alleged misrepresentations occurring after that date.
In developing its Offer to Purchase in 1995, Interbrew alleges that its financial ad-visors placed special reliance on Brascan’s oral representations at a June 29, 1995 meeting, Brascan’s written representations in its publicly-filed Annual Information Form for the year ending December 31, 1994 filed on May 19,1995 (the “1995 Information Form”), and on statements made in Labatt’s financial statements filed with the SEC as part of its 1994 Annual Report. See Cmplt. at ¶¶21, 25.
Nowhere does Interbrew allege that any face-to-face meetings — either with Labatt officers and auditors or with Interbrew officers—occurred in the United States. It is not alleged that the oral representations made by Brascan at the June 29, 1995 meeting took place in the United States. Nor does Interbrew allege that the 1995 Information Form was filed in the United States. Similarly, Interbrew’s allegations concerning alleged misrepresentations made by Brascan to “the market” refer to the Toronto Stock Exchange where Labatt shares traded “[p]ri- or to and at the time of the tender offer.” See Cmplt. at ¶24. As the conduct test focuses on Defendant’s activities in the United States, neither the statements made at the June 29,1995 meeting, the 1995 Information Form, nor allegations regarding “the market” can be used to further Interbrew’s claims under U.S. securities laws.
Remaining, however, is Interbrew’s allegation that Brascan caused similar misrepresentations to appear in Labatt’s Annual Reports, filed in the United States with the SEC and relied on by Interbrew’s advisors in preparing their Offer to Purchase. Filings with the SEC have been found to support subject matter jurisdiction.
See Itoba,
However, the Second Circuit’s reasoning in
Europe and Overseas
is again instructive. There, the court reiterated the traditional requirement under the conduct test “that U.S. activity directly cause the harm to the
*432
foreign interest ...” and acknowledged that the plaintiff, EOC, relied upon the allegedly misleading information while present in the United States and “such reliance was the direct cause of the loss sustained by EOC.”
Europe and Overseas,
Even assuming this Court were to pierce the corporate veil and find that Brascan can be held accountable for the alleged misrepresentations in Labatt’s 1994 SEC filing, the surrounding circumstances make the case for finding jurisdiction tenuous. Although Inter-brew does not rely on Europe and Overseas, that opinion provides the strongest support for Interbrew’s position. Interbrew argues that jurisdiction has been found under the conduct test, in predominantly foreign securities transactions, when, in addition to some incidental “communications with or meetings in the United States,” id. at 130, there is a further link to the United States, such as harm to a U.S. party or significant economic activity connecting the parties to the United States. Id. Interbrew suggests that such a connection exists because Labatt maintains substantial operations in the United States, operations which were a significant factor in Interbrew’s decision to purchase the Labatt shares.
In favor of this position, Interbrew cites
AVC Nederland B.V. v. Atrium Inv. Partnership,
Interbrew might argue that its facts are closer to those in
Nederland
than those in
Europe and Overseas.
While this is partially true,
Nederland
is, ultimately, distinguishable.
Nederland
involved an allegedly fraud-tainted deal consummated abroad concerning economic activity connecting both the plaintiff and defendants to the United States. But one of the
Nederland
defendants was a general partnership formed in Georgia, and the plaintiff maintained that much of the negotiation, and all of the Jleged misrepresentations, occurred in the United States. These factors are absent here. Thus, as in
Europe and Overseas,
this court lacks jurisdiction.
See also, Fidenas AG v. Compagnie Internationale Pour L’Informatique Oil Honeywell Bull S.A.,
IV. Conclusion
The Complaint fails to allege that this Court has subject matter jurisdiction under either the conduct or the effects test, whether applied separately or in combination. For this reason, Defendant’s 12(b)(1) motion to dismiss is granted. Because subject matter jurisdiction is based on Plaintiffs Exchange Act claim, the Court declines to exercise
*433
jurisdiction over Plaintiffs common law fraud and negligent misrepresentation claims.
See Carnegie-Mellon Univ. v. Cohill,
SO ORDERED:
Notes
. Rule 10b-5 provides: "It shall be unlawful for any person, directly or indirectly, by use of any means or instrumentality of interstate commerce, or of the mails, or of any facility of any national securities exchange, (1) to employ any device, scheme, or artifice to defraud, (2) to make any untrue statement of a material fact or to omit to state a material fact necessary in order to make the statements made, in the light of the circumstances under which they were made, not misleading, or (3) to engage in any act, practice, or course of business which operates or would operate as a fraud or deceit upon any person, in connection with the purchase or sale of any security.”
. While Interbrew's Offer to Purchase was dated June 14, 1995, Interbrew was free to increase or decrease the offering price for Labatt shares at any time prior to the close of Interbrew’s tender offer, under both U.S. and Canadian rules. See 17 C.F.R. § 240.14e-1(b); Securities Act, R.S.O., Part XX, § 98(4)—(5) (1994) (Can.).
. In
Itoba,
the court also sustained jurisdiction. In that case, a Channel Islands company, wholly owned by a Bermuda company, sued a London-based holding company, Lep Group PLC ("Lep”), whose stock traded on the London Exchange. The court found the defendant subject to the securities fraud laws based on submissions of Form 20-F to the SEC. But there, the SEC filings were made in an attempt to create a U.S. market for Lep's shares by issuing American Depository Receipts (ADRs) traded on the NASDAQ exchange.
Itoba,
